| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.0085 | 0.9 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |